RT @GavinGiovannoni: #Alemtuzumab is a reasonable rescue therapy in a cohort of 50 German RRMSers with breakthrough disease on #Fingolimod.…
81 followers
623 followers
Alemtuzumab vs fingolimod in #multiplesclerosis: a multi-center observational study. https://t.co/54U9mwLrp9 https://t.co/ROuQrI8VjO https://t.co/ifhiLkH5Xr
4,247 followers
RT @GavinGiovannoni: #Alemtuzumab is a reasonable rescue therapy in a cohort of 50 German RRMSers with breakthrough disease on #Fingolimod.…
506 followers
RT @OhioHealthMS: "Alemtuzumab as rescue therapy in a cohort of 50 relapsing-remitting MS patients with breakthrough disease on fingolimod:…